Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
47,649,567
-
Total 13F shares
-
25,558,517
-
Share change
-
+25,558,517
-
Total reported value
-
$593,435,106
-
Price per share
-
$23.26
-
Number of holders
-
35
-
Value change
-
+$593,435,106
-
Number of buys
-
35
Institutional Holders of Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP) as of Q2 2024
As of 30 Jun 2024 Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP) had 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 25,558,517 shares of stock of the company.
Largest 10 holders included FMR LLC, ARCH Venture Management, LLC, Cormorant Asset Management, LP, Capital International Investors, JOHNSON & JOHNSON, Sofinnova Investments, Inc., T. Rowe Price Investment Management, Inc., PRICE T ROWE ASSOCIATES INC /MD/, ALLIANCEBERNSTEIN L.P., and PERCEPTIVE ADVISORS LLC.
This table shows 35 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.